Regeneron Pharmaceuticals Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Regeneron Pharmaceuticals

REGN 784.45

-0.4%

Nov 26 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: Biotech Jim	5/18/2015 11:47:12 AM
	of 3559

Regeneron lobbying for its database to be the linchpin of Obama's Precision Medicine program May 18, 2015 \| By Nick Paul Taylor fiercebiotechit.com An excerpt... "Regeneron Pharmaceuticals ( $REGN) is lobbying for the exome sequencing database it is building with Geisinger Health System to become the linchpin of President Obama's Precision Medicine program. The idea is for a consortium of drugmakers to fund the database, giving Regeneron a way of clawing back some of its investment while waiting for long-term drug R&D bets to pay off."

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next